Oramed to Present a Scientific Poster at International Diabetes Federation Congress December 2, 2019 Press Releases
Oramed Patent Granted in Japan for Protease Inhibitor, a Key Component of Platform Technology November 21, 2019 Press Releases
Oramed Provides Highlights and Data From Its Phase IIb Oral Insulin Study Investor Event November 19, 2019 Press Releases
Oramed Pharmaceuticals to Discuss Positive Phase IIb Data at Investor Event and Conference Call on Monday, November 18th November 14, 2019 Press Releases
Oramed Announces Successful Phase IIb Study of Oral Insulin in Type 2 Diabetes November 12, 2019 Press Releases
Oramed Announces Last Patient Treated in Pivotal Phase IIb Trial of Oral Insulin ORMD-0801 September 17, 2019 Press Releases
